首页 | 本学科首页   官方微博 | 高级检索  
   检索      

高压氧治疗糖尿病视网膜病变的研究进展
引用本文:王严,匡洪宇,陈萍,李月,唐蔚,王峰.高压氧治疗糖尿病视网膜病变的研究进展[J].现代生物医学进展,2014,14(24):4787-4789.
作者姓名:王严  匡洪宇  陈萍  李月  唐蔚  王峰
作者单位:哈尔滨医科大学附属第一医院内分泌科; 哈尔滨医科大学附属第一医院高压氧科
基金项目:黑龙江省自然科学基金面上项目(D201253)
摘    要:糖尿病视网膜病变是糖尿病最常见、最主要的微血管并发症之一,具有高发病率,高致盲率的特点,严重影响了人类的生存质量。控制高血糖和改善组织缺氧无疑是防治糖尿病微血管病变的有效方法。如果对糖尿病视网膜病变及时进行治疗,能延缓其发展并能提高病人的生活质量。近年来,随着对糖尿病发病机制的深入研究,很多方法用于防治糖尿病视网膜病人都取得了一定的疗效。而高压氧治疗是许多急慢性疾病的首选治疗方法。已有基础和临床研究证实,高压氧治疗对糖尿病视网膜病变安全有效。因此,作为一种新疗法,高压氧疗法可能会为糖尿病视网膜病变的治疗带来更广泛的应用前景。

关 键 词:高压氧  糖尿病视网膜病变  治疗

Research Progress of Hyperbaric Oxygen in the Treatment of Diabetic Retinopathy
WANG Yan,KUANG Hong-yu,CHEN Ping,LI Yue,TANG Wei,WANG Feng.Research Progress of Hyperbaric Oxygen in the Treatment of Diabetic Retinopathy[J].Progress in Modern Biomedicine,2014,14(24):4787-4789.
Authors:WANG Yan  KUANG Hong-yu  CHEN Ping  LI Yue  TANG Wei  WANG Feng
Abstract:Diabetic retinopathy is one of the most common and severe microvascular complications of diabetes. with the characteristics of the high incidence, the quality of human survival has been damaged. Control high blood glucose and improve the organization of oxygen are undoubtedly effective methods of the prevention and control of diabetes microvascular lesions. However, effective therapy in time can prevent the development of diabetic retinopthy and improve the quality of life. In recent years, following advanced research of diabetic etiopathogenseis, further advances in many methods have shown promise in the treatment of diabetic retinopthy. And hyperbaric oxygen therapy is the first choice of many acute or chronic diseases. It has been proved by basic experiments and clinical trials that hyperbaric oxygen therapy is safe and effective for diabetic retinopathy. Therefore, as a kind of new therapy, hyperbaric oxygen therapy may bring more extensive application prospect.
Keywords:Hyperbaric oxygen  Diabetic retinopathy  Therapy
本文献已被 CNKI 等数据库收录!
点击此处可从《现代生物医学进展》浏览原始摘要信息
点击此处可从《现代生物医学进展》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号